Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2,3-di(hydroxymethyl)quinoxaline Di-n-oxide
2. 2,3-quinoxalinedimethanol, 1,4-dioxide
3. 2,3-quinoxalinedimethanol-1,4-dioxide
4. Chinoxalindimethanol Dioxide
5. Dioxydine
6. Sulfonium, Trimethyl-, 2,3-bis(hydroxymethyl)quinoxaline-1,4-di-n-oxide
1. 17311-31-8
2. Dioxydine
3. 2,3-bis(hydroxymethyl)-1-oxoquinoxalin-1-ium-4(1h)-olate
4. 2,3-quinoxalinedimethanol, 1,4-dioxide
5. [3-(hydroxymethyl)-1-oxido-4-oxoquinoxalin-4-ium-2-yl]methanol
6. (3-hydroxymethyl-1,4-dioxy-quinoxalin-2-yl)-methanol
7. (1,4-dioxidoquinoxaline-2,3-diyl)dimethanol
8. 2,3-quinoxalinedimethanol 1,4-dioxide
9. Dioxydinum
10. Metrosept
11. Chemdiv3_000060
12. 16bop9xe0f
13. Oprea1_028820
14. Cbdive_002950
15. Schembl11144192
16. Dtxsid00169525
17. Chinoxalindimethanol Dioxide
18. Hms1473c16
19. Albb-028963
20. Zinc2018052
21. Bbl027205
22. Mfcd00225753
23. Stk366604
24. Stl069540
25. Akos000541267
26. Akos005111023
27. Sdccgmls-0064536.p001
28. Idi1_019378
29. Vs-08499
30. Chinoxalindimethanol Dioxide [who-dd]
31. Ft-0682662
32. A811489
33. Ag-690/11354175
34. Sr-01000390051
35. 2,3-di(hydroxymethyl)quinoxaline Di-n-oxide
36. Q4138123
37. Sr-01000390051-1
38. Brd-k62858371-001-01-0
39. [3-(hydroxymethyl)-1,4-dioxido-2-quinoxalinyl]methanol
40. 2,3-di(hydroxymethyl)quinoxaline 1,4-di-n-oxide
41. [3-(hydroxymethyl)-1,4-dioxido-quinoxaline-1,4-diium-2-yl]methanol
42. 2,3-bis(hydroxymethyl)quinoxaline-1,4-diium-1,4-bis(olate)
43. 2,3-bis-hydroxymethyl-2,3-dihydro-quinoxaline-1,4-dioxide
44. 2,3-bis(hydroxymethyl)-1-oxo-1,4-dihydro-1??-quinoxalin-1-ylium-4-olate
45. Sulfonium, Trimethyl-, 2,3-bis(hydroxymethyl)quinoxaline-1,4-di-n-oxide
Molecular Weight | 222.20 g/mol |
---|---|
Molecular Formula | C10H10N2O4 |
XLogP3 | -0.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 222.06405680 g/mol |
Monoisotopic Mass | 222.06405680 g/mol |
Topological Polar Surface Area | 86.8 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 299 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Mutagens
Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)
About the Company : Farmak International is a leading GMP EU certified pharmaceutical manufacturer in Ukraine established in 1925 with FDA inspected site for production of food supplement. Company spe...
Regulatory Info :
Registration Country : Ukraine
Brand Name : Dioxydine
Dosage Form : Solution for Injection
Dosage Strength : 10MG/ML
Packaging : 10ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?